Pharmatech Exscientia jumps in U.S. stock market debut

Quest PharmaTech

01/10/2021 19:43

** American depositary shares (ADSs) of Exscientia plc
 EXAI.O  opened more than 23% above their IPO price in market
debut
    ** ADSs opened at $27.14 compared to their IPO price of $22
each
    ** EXAI sold 13.85 ADSs in an upsized IPO, raising about
$304.7 mln 
    ** Co raised an additional $160 mln in a concurrent private
placement
    ** EXAI is an Oxford, United Kingdom-based artificial
intelligence-driven drug discovery company
    ** Goldman Sachs, Morgan Stanley, BofA Securities and
Barclays were the joint book-running managers for the offering

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))